Machine learning to distinguish EGPA from HES
Official title: The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome
Run by Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07275190 · Data updated 2026-11-12
This project will test whether machine learning applied to clinical, lab, and instrument data can help tell EGPA apart from HES and predict how patients respond to treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Fondazione IRCCS Policlinico San Matteo di Pavia Academic / other |
| Locations | 1 site (Pavia) |
| Status | Recruiting |
| Started | June 1, 2025 |
| Main results expected | September 2026 |
| Study ends | December 2026 |
| Registry record updated | December 10, 2025 |
| Trial ID | NCT07275190 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with a confirmed diagnosis of EGPA or HES who can provide informed consent (or have an authorized representative) are eligible.
✕Probably not a fit
People without a confirmed EGPA or HES diagnosis, those with other known causes of eosinophilia, and individuals expecting direct therapeutic benefit are unlikely to gain personal medical benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will collect clinical history, laboratory results, instrumental data, and blood samples from adults diagnosed with EGPA or HES at a single center in Pavia, Italy. The collected data will be processed and analyzed with machine learning algorithms to identify patterns and features that differentiate the two conditions and to develop models predicting treatment response. Participation involves informed consent and blood draws for laboratory assessment; no investigational drugs or therapeutic interventions are given. The ultimate aim is to produce an algorithmic tool that could support clinicians in making more accurate and timely diagnoses.
Why it matters
Potential benefit: If successful, this approach could speed up and improve diagnostic accuracy between EGPA and HES, helping clinicians choose more appropriate treatments sooner.
How similar studies have gone: Machine learning has shown promise in differentiating related inflammatory and hematologic disorders, but applying it specifically to distinguish EGPA from HES is relatively novel and not yet widely validated.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. 18 years of age or over 2. A diagnosis of EGPA or HES 3. Willing and able to give informed written consent, or willing to give permission for a nominated friend or relative to provide written informed assent if they are unable to do so because of physical disabilities Exclusion Criteria: 1. Lack of a confirmed diagnosis of EGPA or HES. 2. Other causes of eosinophilia
Where it's running
-
Fondazione IRCCS Policlinico San Matteo, SC Reumatologia
Pavia, Italy Recruiting
Study contacts
- Study coordinator: Carlomaurizio Montecucco
- Email: carlomaurizio.montecucco@unipv.it
- Phone: 390382502948
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Registry of patients with eosinophilia affecting the respiratory system
This study is gathering information from patients with eosinophilic lung diseases to better understand how their blood eosinophil levels relate to their breathing problems and overall health.
-
Investigating the Role of Nasal Microbiome in Eosinophilic Granulomatosis with Polyangiitis
This study is trying to see how the bacteria in the nose affect the immune system in people with Eosinophilic Granulomatosis with Polyangiitis and related conditions, and whether a new treatment can change that.
-
AirGo Respiratory Monitoring During Lung Resection
Patients undergoing lung resection will wear the AirGo device to continuously monitor breathing before and after surgery to see if it helps track ventilation alongside standard checks.
-
Experiences After Risk-Reducing Mastectomy in BRCA1/2 Carriers
This study asks women with BRCA1/2 or related variants who had risk-reducing mastectomy to share their experiences and satisfaction to see what factors are connected to how happy they are with the outcome.
-
Natural history of eosinophilic esophagitis in adults and children
This observational study tests how eosinophilic esophagitis progresses over time in people 5 years and older to understand symptoms and outcomes.
-
COVID-19 Registry at San Matteo (SMACORE) - patient-matching observational registry
This registry tests how COVID-19 patients are being treated and progress across San Matteo in Pavia to understand patterns and outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.